Taking a quick look at the historical performance of Nabriva Therapeutics plc (NASDAQ:NBRV) shares, we have noted that the stock price for the previous week is 25.74%. Looking back over the past month, company shares are 11.40%. For the past quarter, shares have performed 24.51%. Going further back to the beginning of the calendar year, company shares are 73.97%. If we scroll back to the full year reading, shares have performed -5.93%. Investors may be trying to decide if it is a good time to get into a particular stock, or whether to exit a position that has turned sour. Whatever the case, outperforming the market is on the minds of many dedicated equity market enthusiasts.

Investors might be trying to figure out the best way to approach the stock market. After creating a plan that includes a list of stocks to purchase, investors may be looking to gauge the best time to enter the trade. With markets still cruising along at high altitudes, investors may be worried about buying at the top. Most individuals would probably agree that getting out before the market drops would be the best play. Obviously this is much easier said than done. If the warning signs were blatant, everyone would know exactly when to sell and when to re-buy. When the stock market has a big decline, the natural instinct is generally to sell in order to protect gains or eliminate further losses. Trying to time the market can have negative implications for investors who are not prepared to handle extremely volatile market conditions. Being prepared for any sudden change in the overall economy or stock market conditions may help the investor stay afloat for the long haul.

Shares of Nabriva Therapeutics plc (NASDAQ:NBRV) have been recently spotted trading -22.32% off of the 52-week high price. On the other end, company shares have been noted 126.79% away from the low price over the last 52-weeks. Switching over to some distances from popular moving averages, we see that the stock has been recorded 13.60% away from the 200 day moving average. Moving closer, we can see that shares have been trading 20.61% off of the 20-day moving average. Investors may be closely following the current stock price in relation to moving averages. This may assist with figuring out if a breakout or reversal could be in the cards. Knowing when to ride the surge rather than stay on the sidelines, can be a difficult decision even for veteran investors.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Focusing on some other company information, we can see that Nabriva Therapeutics plc (NASDAQ:NBRV) has a beta of 2.44. Beta indicates the tendency of a stock’s returns to respond to market swings. A beta of 1 indicates that the stock price moves with the market. A beta under 1 indicates that the stock is less volatile than the market in theory. A beta value over one would indicate the opposite. In terms of volatility, shares have been noted at 8.59% for the week, and 11.50% for the past month. Investors often keep a close eye on any irregular stock volume. Traders and technical analysts have the ability to use volume to help measure the strength of a particular move. Investors may also view volume levels when the stock price is nearing significant support or resistance levels, in order to confirm a breakout in either direction.

We can now shift our focus to some alternate company data on shares of Nabriva Therapeutics plc (NASDAQ:NBRV). The stock has a current ATR of 0.20. When applying indicators for technical analysis, traders and investors may choose to examine the ATR or average true range. The ATR measures the volatility of a stock on a day-to-day basis. The average true range is typically based on 14 periods and may be calculated daily, weekly, monthly, or intraday. The ATR is not considered a directional indicator, but it may reflect the strength of a particular move. As we move into the second half of the year, investors may be looking to jumpstart their portfolios. Many equity investors may be wondering if the stock markets will find renewed energy and continue higher, or if a major correction is on the horizon.

As the next round of earnings reports come into the spotlight next quarter, investors may be deciding how to get into the best position to make the most profitable trades. Earnings reports have the ability to influence stock prices dramatically. Sometimes it can be hard to figure out which way the price will go even if the reported numbers are up to snuff. Some investors enjoy the frantic trading opportunities around earnings reports, and others will stay as far away as possible. Even if the investor isn’t planning on making any moves during earnings season, it may be wise to follow what companies are reporting. If the numbers from a certain holding come in way out of whack, it may be necessary to do some in-depth research to try and find out the reason. Investors that make sure that all the bases are covered will typically find it easier to make sense out of certain anomalies that pop up in the markets from time to time. Putting in the extra time and effort to understand the ins and outs of a particular stock may help boost the novice investor up to the next level. Every investor wants their trades to be profitable, and doing that little extra piece of homework could be just what the finance doctor ordered for staying on top of the stock market.